Honeywell International is a diversified technology and manufacturing company that operates in various sectors, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. The company develops and provides innovative products, services, and solutions designed to enhance efficiency, safety, and sustainability in various industries. Honeywell focuses on leveraging advanced software and automation to improve performance and operational capabilities for its customers, while also emphasizing environmentally responsible practices and the development of cutting-edge technologies. Read More
The latest inflation data released this April has sent a shockwave through global markets, revealing a staggering 12.5% year-over-year surge in energy prices. This spike, the sharpest seen in over two years, has abruptly halted the narrative of a "soft landing" and forced investors to grapple with a renewed
Shares of Carrier Global Corp (NYSE:CARR) experienced a significant 5.4% surge today, April 10, 2026, closing at a multi-month high of $61.46. The jump marks a pivotal moment for the industrial giant, which has spent the last two years aggressively restructuring its portfolio to become a "pure-play"
In a move that underscores the U.S. military’s continued reliance on its primary aerial refueling platform, the U.S. Air Force has awarded Boeing (NYSE: BA) a $101.3 million contract for the procurement of KC-46 Pegasus parts and support services. Announced on April 6, 2026, the undefinitized
As the spring of 2026 unfolds, the financial world is transfixed by a psychological and symbolic threshold: the 50,000-point mark on the Dow Jones Industrial Average. On April 7, 2026, the index continues to hover in a high-stakes consolidation zone, having briefly breached the historic 50,000 milestone earlier
As of April 7, 2026, the financial markets are bracing for a pivotal week that could redefine the economic landscape for the remainder of the year. Investors and policymakers are fixated on the upcoming release of the March Consumer Price Index (CPI) and Producer Price Index (PPI) reports, which are
Date: April 7, 2026 Introduction In the mid-2020s, the global economy underwent a structural shift, pivotally centered on the rapid expansion of Generative AI. While much of the public's attention was fixed on chipmakers and cloud service providers, a select group of "picks and shovels" companies became the indispensable foundation of this digital era. At [...]
AINewsWire Editorial Coverage : As regulatory expectations intensify and manufacturing complexity grows, pharmaceutical companies are moving beyond traditional quality systems toward a new paradigm: embedding artificial intelligence (“AI”) directly into operations as a real-time compliance layer. Rather than relying on retrospective audits and manual oversight, AI-driven systems now continuously monitor, validate and optimize production processes to align with evolving Good Manufacturing Practice (“GMP”) standards. This structural shift is increasingly visible across the industry and aligns with companies such as Oncotelic Therapeutics Inc. (OTCQB: OTLC) ( Profile ), which operate at the intersection of life sciences and advanced digital technologies, reflecting the broader movement toward intelligent, automated compliance frameworks. With its focus on AI, Oncotelic joins other AI-focused entities, including NVIDIA Corp. (NASDAQ: NVDA), Amazon.com Inc. (NASDAQ: AMZN), Honeywell International Inc. (NASDAQ: HON) and Omnicell Inc. (NASDAQ: OMCL), that are leading…
The AI trade has moved in waves—semiconductors, then software, then cloud infrastructure. Each one rewarded early investors and punished latecomers. The next wave is already building, and it has nothing to do with data centers or chatbots. It's edge AI, the technology that puts artificial intelligence directly inside machines. Keith Kaplan, CEO of TradeSmith, has been tracking this shift closely, and he sees three companies across very different risk profiles positioned to ride it.
AUSTIN, Texas, April 07, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: As regulatory expectations intensify and manufacturing complexity grows, pharmaceutical companies are moving beyond traditional quality systems toward a new paradigm: embedding artificial intelligence (AI) directly into operations as a real-time compliance layer. Rather than relying on retrospective audits and manual oversight, AI-driven systems now continuously monitor, validate and optimize production processes to align with evolving Good Manufacturing Practice (GMP) standards. This structural shift is increasingly visible across the industry and aligns with companies such as Oncotelic Therapeutics Inc. (OTCQB: OTLC) (profile), which operate at the intersection of life sciences and advanced digital technologies, reflecting the broader movement toward intelligent, automated compliance frameworks. With its focus on AI, Oncotelic joins other AI-focused entities, including NVIDIA Corp. (NASDAQ: NVDA), Amazon.com Inc. (NASDAQ: AMZN), Honeywell International Inc. (NASDAQ: HON) and Omnicell Inc. (NASDAQ: OMCL), that are leading out in the space.
Date: April 2, 2026 Introduction In the evolving landscape of industrial technology, few companies have undergone a transformation as profound as Acuity Brands, Inc. (NYSE: AYI). Once regarded primarily as a legacy manufacturer of light fixtures and "dumb" bulbs, the Atlanta-based giant has spent the last five years aggressively reinventing itself. Now operating under the [...]
The American industrial engine showed surprising grit in March 2026, as the Institute for Supply Management (ISM) reported its third consecutive month of expansion. The headline Manufacturing Purchasing Managers' Index (PMI) climbed to 52.7, comfortably surpassing economist forecasts and signaling a sustained recovery for a sector that had struggled
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it m...
In a move that signals the definitive end of its era as a "traditional" chemical and water treatment provider, Ecolab (NYSE: ECL) has finalized its landmark $4.75 billion acquisition of CoolIT Systems as of late March 2026. This aggressive maneuver into the specialized world of direct liquid cooling (DLC)
Wall Street analysts change outlook on top names. Check analyst ratings page for upgrades, downgrades, and initiations. See others' views on these stocks.
A growing digital procurement network is strengthening its position as a Global NSN Parts Supplier, Aviation Parts Distributor , and Electronic Parts Supplier , connecting buyers and suppliers across aviation, defense, and electronic industries worldwide. By leveraging multiple specialized platforms, the network captures high-intent demand and delivers consistent RFQs, enabling faster and more reliable sourcing.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the general industrial machinery industry, including Honeywell (N...
Date: March 25, 2026 Introduction The Chemours Company (NYSE: CC) is currently standing at one of the most pivotal crossroads in its decade-long history as an independent entity. As a global leader in performance chemicals, Chemours provides the foundational materials that power everything from air conditioning and semiconductor manufacturing to high-end automotive coatings and the [...]
